Ontario start-up makes major deal to develop cancer-fighting viruses

Posted on Wednesday, October 11, 2017

Dr. David Stojdl, Dr. John Bell and Dr. Brian Lichty

Dr. David Stojdl, Dr. John Bell and Dr. Brian Lichty 

Canadian academic institutions and research organizations are congratulating Turnstone Biologics on a new partnership with AbbVie to develop cancer-fighting viruses (also called oncolytic viral immunotherapies).

Turnstone was founded in Ottawa based on research led by Dr. John Bell (from The Ottawa Hospital and uOttawa - middle), Dr. Brian Lichty (from McMaster University - right) and Dr. David Stojdl (from the Children’s Hospital of Eastern Ontario and uOttawa - left). The Ontario Institute for Cancer Research (OICR) and BioCanRx have also played a key role in advancing the technology.

Read the full release

Media inquiries

Amélie Ferron-Craig
Media Relations Officer
Cell: 613-863-7221
aferronc@uOttawa.ca

Back to top